De novo hepatocellular carcinoma after liver transplantation

Sammy Saab, Kali Zhou, Edward K. Chang, Ronald W. Busuttil

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Liver transplantation is the definitive therapy for patients with advanced liver disease and its complications. Patients who are transplanted with a diagnosis of hepatocellular carcinoma (HCC) are at risk of recurrent cancer, and these patients are monitored on a regular basis for recurrence. In contrast, de novo HCC following liver transplantation is a very rare com-plication, and recipients without HCC at the time of transplantation are not screened. We describe the clinical features of de novo HCC over a decade after achieving a sustained viral response with treatment of hepatitis C and two decades after liver transplantation. Our case highlights the necessity of screening for HCC in the post-transplant patient with advanced liver disease even after viral clearance.

Original languageEnglish (US)
Pages (from-to)284-287
Number of pages4
JournalJournal of Clinical and Translational Hepatology
Issue number4
StatePublished - 2015


  • De novo hepatocellular carcinoma
  • Liver transplantation

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'De novo hepatocellular carcinoma after liver transplantation'. Together they form a unique fingerprint.

Cite this